People: Affymetrix Inc (AFFX.O)

AFFX.O on Nasdaq

8.38USD
11:07am EDT
Price Change (% chg)

$0.07 (+0.84%)
Prev Close
$8.31
Open
$8.31
Day's High
$8.43
Day's Low
$8.22
Volume
103,896
Avg. Vol
694,720
52-wk High
$9.80
52-wk Low
$5.90

Search Stocks

Summary

Name Age Since Current Position

Stephen Fodor

60 2009 Executive Chairman of the Board

Frank Witney

60 2011 President, Chief Executive Officer, Director

Gavin Wood

44 2013 Chief Financial Officer, Executive Vice President

Andrew Last

54 2014 Chief Operating Officer, Executive Vice President

David Weber

60 2014 Executive Vice President, Chief Commercial Officer

Robert Wayman

68 2010 Lead Independent Director

Nelson Chan

52 2010 Independent Director

Gary Guthart

48 2009 Independent Director

Jami Nachtsheim

55 2010 Independent Director

Robert Trice

68 2006 Independent Director

Doug Farrell

Vice President - Investor Relations & Treasury

Biographies

Name Description

Stephen Fodor

Dr. Stephen P. A. Fodor, Ph.D., is Executive Chairman of the Board of Affymetrix Inc. Dr. Fodor has served as director since 1993. He served as Chief Executive Officer from 1997 to 2008 and as Chairman from 1999 to present. At various times between 1993 and 1997, Dr. Fodor served as our President, Chief Operating Officer and Chief Technology Officer. Dr. Fodor was Vice President and Director of Physical Sciences at the Affymax Research Institute from 1989 to 1993. Dr. Fodor is the founder and Chief Executive Officer of Cellular Research, Inc. and serves as a Trustee of the Carnegie Institution for Science and as a member of the National Academy of Engineering. Dr. Fodor also serves on a variety of scientific advisory boards. The Board of Directors selected Dr. Fodor as a director nominee because he is the founder of the Company and our former Chief Executive Officer. The Board of Directors values Dr. Fodor’s extensive knowledge of the Company and our industry, his scientific vision and his perspective on emerging technologies and markets.

Frank Witney

Dr. Frank R. Witney, Ph.D., is President, Chief Executive Officer, Director of Affymetrix, Inc. Dr. Witney served as President and Chief Executive Officer of Dionex Corporation from April 2009 to May 2011. Between December 2008 and April 2009, Dr. Witney served as our Executive Vice President and Chief Commercial Officer. Previously, Dr. Witney served as President and Chief Executive Officer of Panomics, Inc. from July 2002 to December 2008. Dr. Witney is a member of the Board of Directors of Cerus Corporation. The Board of Directors selected Dr. Witney as a director nominee because the Board values Dr. Witney’s industry experience and his perspective as the Chief Executive Officer of the Company.

Gavin Wood

Mr. Gavin Wood has been appointed as Chief Financial Officer, Executive Vice President of Affymetrix, Inc., effective May 20, 2013. Mr. Wood has held a number of financial roles at Affymetrix, including Vice President, Finance, International Controller, responsible for Europe and Asia Pacific. Prior to joining Affymetrix, Mr. Wood held a number of positions at the Unipart Group of Companies, including Business Unit Controller. Mr. Wood is a Chartered Accountant who qualified with the London Accountancy Practice Morgan Brown Spofforth in 1997 before continuing his career with Grant Thornton LLP.

Andrew Last

Dr. Andrew J. Last, Ph.D., is Chief Operating Officer, Executive Vice President of Affymetrix Inc. He joined the company in December 2009 and currently serves as Executive Vice President, Genetic Analysis Business Unit.Prior to joining Affymetrix, Dr. Last served on the leadership team of BD Biosciences Cell Analysis Unit, a segment of Becton Dickinson and Company, from 2004 to 2009, where he was Vice President, Global Marketing & Strategic Planning and General Manager of the San Diego-based Pharmingen business. Before joining Becton Dickinson, Dr. Last was a member of Applera Corporation’s Applied Biosystems unit leadership team from 2002 to 2004 as Vice President & General Manager of the Gene Expression business.

David Weber

Mr. David Weber is Executive Vice President, Chief Commercial Officerof Affymetrix Inc. Between December 2011 and February 2013, he served as Senior Vice President, Global Commercial Operations. From June 2010 to December 2011, Mr. Weber was a consultant to various biotechnology companies. Mr. Weber was at Cyntellect Inc. as its Vice President, Sales from July 2009 to June 2010. Mr. Weber was with The Linus Group from February 2008 to June 2009 as its Vice President of the Life Sciences Practice. Previously, Mr. Weber served as President and CEO of Eksigent Technologies, Senior Vice President of Marketing and Business Development of Stratagene Corp., and President, Americas Region, for Amersham Biosciences (GE Healthcare).

Robert Wayman

Mr. Robert P. Wayman serves as Lead Independent Director of Affymetrix Inc. Mr. Wayman served as Executive Vice President and Chief Financial Officer of Hewlett-Packard Company from 1984 until his retirement in December 2006. Mr. Wayman also served as Interim Chief Executive Officer of Hewlett-Packard Company from February 2005 through March 2005 and served on the Board of Directors of Hewlett-Packard Company from February 2005 to March 2007 and from 1993 to 2002. Mr. Wayman is a member of the Board of Directors of CareFusion Corp. and Textura Corporation. The Board of Directors selected Mr. Wayman as a director nominee because of his broad-based financial expertise and business experience. The Board of Directors values Mr. Wayman’s background in finance and company operations, corporate governance and compliance, and as a member of the Audit Committee and the Nominating and Corporate Governance Committee.

Nelson Chan

Mr. Nelson C. Chan is an Independent Director of Affymetrix Inc. Mr. Chan served as Chief Executive Officer of Magellan Navigation, Inc. from 2006 to 2008. From 1992 through 2006, Mr. Chan served in various senior management positions with SanDisk Corporation, including most recently as Executive Vice President and General Manager, Consumer Business. Mr. Chan is Chairman of the Board of Directors of Outerwall, Inc. and a director of Synaptics Incorporated. The Board of Directors selected Mr. Chan as a director nominee because of his substantial experience with public and private companies, both as an executive and as a board member, and his expertise in building profitable technology companies. Mr. Chan also qualifies as a financial expert and serves as Chairman of the Audit Committee. .

Gary Guthart

Dr. Gary S. Guthart Ph.D., is Independent Director of Affymetrix Inc. Dr. Guthart has served as the Chief Executive Officer of Intuitive Surgical, Inc. since January 2010. Dr. Guthart joined Intuitive Surgical, Inc. in April 1996, became Chief Operating Officer in 2006, and was promoted to President in 2007. Prior to joining Intuitive Surgical, Inc., Dr. Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formally Stanford Research Institute). Dr. Guthart serves on the Board of Directors of Intuitive Surgical, Inc. The Board of Directors selected Dr. Guthart as a director nominee because of his experience in the management of complex, high-growth businesses. The Board values Dr. Guthart’s contribution to the Company’s strategic planning and business development efforts and his insights as a member of the Compensation Committee.

Jami Nachtsheim

Ms. Jami Dover Nachtsheim serves as Independent Director of Affymetrix Inc. Ms. Nachtsheim served in a variety of positions with Intel Corporation from 1980 until her retirement in 2000, most recently as Corporate Vice President of the Sales and Marketing Group and Director of Worldwide Marketing. Ms. Nachtsheim is a member of the Board of Directors of FEI Company and The Tech Museum of Innovation. The Board of Directors selected Ms. Nachtsheim as a director nominee because of her extensive experience in bringing high technology products to market and her service as a board member of numerous public and private organizations. The Board values the guidance she provides with respect to market strategies and her contributions as the Chairwoman of the Compensation Committee.

Robert Trice

Dr. Robert H. Trice, Ph.D., serves as an Independent Director of Affymetrix Inc. Dr. Trice served as Senior Vice President for Business Development at Lockheed Martin Corporation from October 1998, and assumed additional duties as Senior Vice President for Strategy and Business Development at Lockheed Martin Corporation from March 2009 until his retirement in January 2011. The Board of Directors selected Dr. Trice as a director nominee because of his broad experience in government relationships (many of our large customers are government institutions) and his extensive background as a business development leader. The Board values his financial literacy and wide-ranging business competencies, which qualify him to serve on the Audit Committee and the Nominating and Corporate Governance Committee.

Doug Farrell

Basic Compensation

Name Fiscal Year Total

Stephen Fodor

188,970

Frank Witney

1,759,440

Gavin Wood

954,758

Andrew Last

933,163

David Weber

872,003

Robert Wayman

--

Nelson Chan

--

Gary Guthart

--

Jami Nachtsheim

--

Robert Trice

--

Doug Farrell

--
As Of 30 Dec 2013

Options Compensation

Search Stocks